Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.

Reports on insertional "genotoxicity" in patients have created intense interest in characterizing retroviral vector integrations on the genomic level. The retroviral vector SF91m3 was used for transduction of human peripheral blood progenitor cells (PBPC). These PBPC were transplanted into nonobese diabetic/severe combined immunodeficient mice. A total of 186 retroviral vector integration sites were isolated by ligation-mediated PCR from chimeric mouse bone marrow of five PBPC donors, sequenced, and blasted against the human genome. Preferred integration near the transcription start regions, within CpG islands, and within Alu regions was observed. Detailed analysis of targeted RefSeq genes showed a favored integration within the first intron. Integrations were most common in genes coding for signaling proteins, transcription factors, and kinases. In all genes targeted independently multiple times the respective orientation of the provirus within the gene was identical, indicating integration hot spot regions and similar steric determinants for integration sites. Possible explanations for these findings could be nonrandom vector integration, clonal selection due to gene expression interference, or engraftment issues related to gene insertion in signaling and cell cycle genes. The low frequency of integrations in exons may be reassuring as to the safety of retroviral gene therapy with normal human PBPC.

• Publication year

  2004

• Venue

  Molecular Therapy

• Publication date

  2004-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.YMTHE.2004.08.001PMID 15509505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RTCGD: retroviral tagged cancer gene database

  2004influential reference
• Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells.

  2004cited by this paper
• Duplication, coclustering, and selection of human Alu retrotransposons.

  2004cited by this paper
• Evi3, a common retroviral integration site in murine B-cell lymphoma, encodes an EBFAZ-related Krüppel-like zinc finger protein.

  2003cited by this paper
• Gene therapy of X-linked severe combined immunodeficiency.

  2003cited by this paper
• Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells.

  2003cited by this paper
• Second Child in French Trial Is Found to Have Leukemia

  2003cited by this paper
• LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

  2003cited by this paper
• Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration

  2003influential reference
• Distinct hematopoietic stem/progenitor cell populations are responsible for repopulating NOD/SCID mice compared with nonhuman primates.

  2003cited by this paper
• Murine Leukemia Induced by Retroviral Gene Marking

  2002cited by this paper
• HIV-1 integration in the human genome favors active genes and local hotspots.

  2002cited by this paper
• High-Throughput Selection of Retrovirus Producer Cell Lines Leads to Markedly Improved Efficiency of Germ Line-Transmissible Insertions in Zebra Fish

  2002cited by this paper
• Targeting retroviral integration?

  2002cited by this paper
• Gene therapy of X-linked severe combined immunodeficiency

  2002cited by this paper
• Large-scale identification of novel potential disease loci in mouse leukemia applying an improved strategy for cloning common virus integration sites

  2002cited by this paper
• Leukemia case triggers tighter gene-therapy controls

  2002cited by this paper
• Initial sequencing and analysis of the human genome

  2001cited by this paper
• The sequence of the human genome (abstract only)

  2001cited by this paper
• Lateral DNA transfer

  2001cited by this paper
• Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1)

  2000cited by this paper
• Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice.

  2000cited by this paper
• Introducing RefSeq and LocusLink: curated human genome resources at the NCBI.

  2000cited by this paper
• Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

  2000influential reference
• MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions.

  2000cited by this paper
• p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27.

  1999cited by this paper
• Design of 5′ Untranslated Sequences in Retroviral Vectors Developed for Medical Use

  1999cited by this paper
• CpG islands as genomic footprints of promoters that are associated with replication origins.

  1999cited by this paper
• Does SINE evolution preclude Alu function?

  1998cited by this paper
• Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1.

  1998cited by this paper
• Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.

  1997cited by this paper
• Bcl-1/cyclin D1 in malignant lymphoma.

  1997cited by this paper
• Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias

  1996cited by this paper
• Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia

  1996cited by this paper
• Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells

  1995cited by this paper
• Targeting retroviral integration

  1995cited by this paper
• Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders.

  1994cited by this paper
• CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

  1994cited by this paper
• L-myc and N-myc in hematopoietic malignancies.

  1993cited by this paper
• Evi-2, a common integration site involved in murine myeloid leukemogenesis

  1990cited by this paper
• The human Evi-1 gene is located on chromosome 3q24-q28 but is not rearranged in three cases of acute nonlymphocytic leukemias containing t(3;5)(q25;q34) translocations.

  1990cited by this paper
• Insertional activation of N-myc by endogenous Moloney-like murine retrovirus sequences in macrophage cell lines derived from myeloma cell line-macrophage hybrids

  1989cited by this paper
• Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines.

  1988cited by this paper
• CpG islands in vertebrate genomes.

  1987cited by this paper
• A preferred region for integration of Friend murine leukemia virus in hematopoietic neoplasms is closely linked to the Int-2 oncogene

  1986cited by this paper
• Sequence the Human Genome

  1986cited by this paper

• Exploring enterovirus pathogenesis and cancer therapy potential through reverse genetics

  2025cites this paper
• Non-viral delivery of RNA for therapeutic T cell engineering.

  2024cites this paper
• Self-Repairing Herpesvirus Saimiri Deletion Variants

  2022cites this paper
• Gene Therapy Clinical Trials

  2020cites this paper
• Gene Therapy for Primary Immunodeficiencies

  2018cites this paper
• Viral-Mediated Gene Therapy for the Generation of Artificial Insulin-Producing Cells as a Therapeutic Treatment for Type 1 Diabetes Mellitus

  2016cites this paper
• A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance

  2016cites this paper
• Analysis of PBase Binding Profile Indicates an Insertion Target Selection Mechanism Dependent on TTAA, But Not Transcriptional Activity

  2016cites this paper
• Transgenerational transmission of systemic mast cell activation disease-genetic and epigenetic features.

  2016cites this paper
• Diabetes reversal via gene transfer: building on successes in animal models

  2015cites this paper
• Concise Review: Lessons Learned From Clinical Trials of Gene Therapy in Monogenic Immunodeficiency Diseases

  2014cites this paper
• The use of β-cell transcription factors in engineering artificial β cells from non-pancreatic tissue

  2014cites this paper
• Gene Therapy Model of X-linked Severe Combined Immunodeficiency Using a Modified Foamy Virus Vector

  2013cites this paper
• Gene Therapy for Primary Immunodeficiencies

  2013cites this paper
• transduced with lentiviral vectors Unaltered repopulation properties of mouse hematopoietic stem cells

  2013cites this paper
• β-Globin Sleeping Beauty Transposon Reduces Red Blood Cell Sickling in a Patient-Derived CD34+-Based In Vitro Model

  2013cites this paper
• Lentiviral vectors: a versatile tool to fight cancer.

  2013cites this paper
• The interdependence between biological and ethical analyses of safety and efficacy in translational gene therapy

  2013cites this paper
• Mature T-cell lymphomagenesis induced by retroviral insertional activation of Janus kinase 1.

  2013cites this paper
• Gene therapy clinical trials worldwide to 2012 – an update

  2013cites this paper
• Regulierte lentivirale Expression von Wachstumsfaktoren in Primärzellen zur Therapie osteochondraler Defekte

  2012cites this paper
• Safety analysis of TCR gene-modified T cells

  2012cites this paper
• MGMT: A Critical DNA Repair Gene Target for Chemotherapy Resistance and for Stem Cell Protection

  2012cites this paper
• Erythroid-Specific Expression of β-globin from Sleeping Beauty-Transduced Human Hematopoietic Progenitor Cells

  2011cites this paper
• Retroviral Insertional Mutagenesis Can Contribute to Immortalization of Mature T Lymphocytes

  2011cites this paper
• Insertional Mutagenesis in Hematopoietic Cells: Lessons Learned from Adverse Events in Clinical Gene Therapy Trials

  2011cites this paper
• Evidence for endogenous retroviruses in human chemokine receptor gene introns: possible evolutionary inferences and biological roles

  2011cites this paper
• Efficacy and safety of Sleeping Beauty transposon-mediated gene transfer in preclinical animal studies.

  2011cites this paper
• An analysis of the human and mouse CXCR5 gene introns

  2011cites this paper
• Therapeutic Modulation of DNA Damage and Repair Mechanisms in Blood Cells

  2011cites this paper
• Safety Analysis in Retroviral Gene Therapy: Identifying Virus Integration Sites in Gene-Modified Cells

  2010cites this paper
• Gene therapy vectors: the prospects and potentials of the cut-and-paste transposons

  2010cites this paper
• Chromosomal Integration of Adenoviral Vector DNA In Vivo

  2010cites this paper
• Vektoren für die Gentherapie von Hautkrankheiten

  2010cites this paper
• Retroviral vectors for gene therapy.

  2010cites this paper
• Chromosomal integration of 1 adenoviral vector DNA in vivo 2 3 4

  2010cites this paper
• The genomic risk of somatic gene therapy.

  2010cites this paper
• Delivering the goods: viral and non-viral gene therapy systems and the inherent limits on cargo DNA and internal sequences

  2010cites this paper
• Gene Expression in Lung and Liver After Intravenous Infusion of Polyethylenimine Complexes of Sleeping Beauty Transposons

  2010cites this paper
• Vectors for gene therapy of skin diseases

  2010cites this paper
• Cell based-gene delivery approaches for the treatment of spinal cord injury and neurodegenerative disorders.

  2010cites this paper
• SNAI2 as a Novel Radioprotector of Normal Tissue by Gene Transfer Using a Lentiviral Bicistronic SIN Vector

  2010cites this paper
• Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O6-methylguanine-DNA methyltransferaseP140K

  2010cites this paper
• LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives

  2010influential citation
• Transcription Factor Binding Sites Are Genetic Determinants of Retroviral Integration in the Human Genome

  2009cites this paper
• Viral sequence integration into introns of chemokine receptor genes

  2009cites this paper
• Safer vectors for gene therapy of primary immunodeficiencies.

  2009cites this paper
• Intradermal delivery of plasmids encoding angiogenic growth factors by electroporation promotes wound healing and neovascularization

  2009cites this paper
• QuickMap: a public tool for large-scale gene therapy vector insertion site mapping and analysis

  2009cites this paper
• Stem cell engineering for the treatment of severe hemoglobinopathies.

  2008cites this paper
• Integration Site Preference of Xenotropic Murine Leukemia Virus-Related Virus, a New Human Retrovirus Associated with Prostate Cancer

  2008cites this paper
• Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors.

  2008cites this paper
• Insertional mutagenesis and clonal dominance: biological and statistical considerations

  2008cites this paper
• A rapid and quantitative assay for measuring neighboring gene activation by vector proviruses.

  2008cites this paper
• Characterization of the Sleeping Beauty transposon system for gene therapy applications

  2008cites this paper
• Multiple Displacement Amplification Enables Large-Scale Clonal Analysis following Retroviral Gene Therapy (cid:1)

  2008cites this paper
• Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy.

  2007cites this paper
• Cynthia E . Dunbar and Stefan Fruehauf Farastuk Bozorgmehr , Stefanie Laufs , Stephanie E . Sellers , Ingo Roeder , Werner J . Repopulating Cells Transplantation of Multidrug Resistance 1 Retrovirally Transduced Long-Term

  2007cites this paper
• Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene.

  2007cites this paper
• The genetic engineering of hematopoietic stem cells: the rise of lentiviral vectors, the conundrum of the ltr, and the promise of lineage-restricted vectors.

  2007cites this paper
• Perspectives for gene therapy of Wilson disease.

  2007cites this paper
• Chromosomal integration in vitro and in vivo of high capacity adenoviral vectors

  2007cites this paper
• Live and let die: in vivo selection of gene-modified hematopoietic stem cells via MGMT-mediated chemoprotection.

  2007cites this paper
• Predicting preferential DNA vector insertion sites: implications for functional genomics and gene therapy

  2007cites this paper
• New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy.

  2007cites this paper
• Gene therapy clinical trials worldwide to 2007—an update

  2007cites this paper
• New Bioinformatic Strategies to Rapidly Characterize Retroviral Integration Sites of Gene Therapy Vectors

  2007cites this paper
• Therapeutic options for patients with severe beta-thalassemia: the need for globin gene therapy.

  2007cites this paper
• Multiple Displacement Amplification Enables Large-Scale Clonal Analysis following Retroviral Gene Therapy

  2007cites this paper
• No Evidence of Clonal Dominance in Primates up to 4 Years Following Transplantation of Multidrug Resistance 1 Retrovirally Transduced Long‐Term Repopulating Cells

  2007cites this paper
• Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection

  2007cites this paper
• Murine leukemia virus vector integration favors promoter regions and regional hot spots in a human T-cell line.

  2006cites this paper
• Integration bias of gammaretrovirus vectors following transduction and growth of primary mouse hematopoietic progenitor cells with and without selection.

  2006cites this paper
• Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells

  2006cites this paper
• Serial Transplantations in Nonobese Diabetic/Severe Combined Immunodeficiency Mice of Transduced Human CD34+ Cord Blood Cells: Efficient Oncoretroviral Gene Transfer and Ex Vivo Expansion Under Serum‐Free Conditions

  2006cites this paper
• Mutations in the gene encoding the low-density lipoprotein receptor LRP4 cause abnormal limb development in the mouse.

  2006cites this paper
• Viral Determinants of Integration Site Preferences of Simian Immunodeficiency Virus-Based Vectors

  2006cites this paper
• The integration profile of EIAV-based vectors.

  2006cites this paper
• Genotoxicity of retroviral integration in hematopoietic cells.

  2006cites this paper
• Mutagenesis and Oncogenesis by Chromosomal Insertion of Gene Transfer Vectors

  2006cites this paper
• Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions

  2006cites this paper
• Polyclonal long-term MFGS-gp91phox marking in rhesus macaques after nonmyeloablative transplantation with transduced autologous peripheral blood progenitor cells.

  2006cites this paper
• Lentiviral vector integration sites in human NOD/SCID repopulating cells

  2006influential citation
• Therapeutic Options for Patients with Severe β-Thalassemia: The Need for Globin Gene Therapy

  2006cites this paper
• New developments in stem cell biology and therapy. First meeting report from the working group of the German Society for Hematology and Oncology.

  2005cites this paper
• Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis.

  2005cites this paper
• Hematopoietic stem cell gene therapy with drug resistance genes: an update

  2005cites this paper
• Genome-wide analysis of retroviral DNA integration

  2005cites this paper
• Awakening gene therapy with Sleeping Beauty transposons.

  2005cites this paper
• Versatility of gene therapy vectors through viruses

  2005cites this paper
• Retroviral DNA integration--mechanism and consequences.

  2005cites this paper
• Retroviral Integration Sites Correlate with Expressed Genes in Hematopoietic Stem Cells

  2005cites this paper
• Perspectives on gene therapy for immune deficiencies.

  2005cites this paper
• Gene therapy for severe combined immunodeficiencies

  2005cites this paper